Response to genetic counseling and testing for the APC I1307K mutation

American Journal of Medical Genetics

Volumn 91, Issue 3, 2000, Pages 207-211

  Johnson, Karen A ^a,c   Rosenblum Vos, Lynne ^a   Petersen, Gloria M ^a,b   Brensinger, Jill D ^a   Giardiello, Francis M ^a   Griffin, Constance A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

APC I1307K; Cancer susceptibility testing; Colorectal cancer; Genetic counseling; Genetic testing; Uptake

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; COLONIC POLYPS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, APC; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; MUTATION; PATIENT ACCEPTANCE OF HEALTH CARE; SEX FACTORS;

EID: 0034117929     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000320)91:3<207::AID-AJMG11>3.0.CO;2-T     Document Type: Article

References (29)

1. Abrahamson J, Moslehi R, Vesprini D, Karlan B, Fishman D, Smotkin D, David YB, Biran H, Fields A, Brunet, JS, Narod SA. 1998. No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews. Cancer Res 58:2919-2922.
2. Andrykowski MA, Munn RK, Studts JL. 1996. Interest in learning of personal genetic risk for cancer: a general population survey. Prev Med 25:527-536.
3. Andrykowski MA, Lightner R, Studts JL, Munn RK. 1997. Hereditary cancer risk notification and testing: how interested is the general population? J Clin Oncol 15:2139-2148.
4. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. 1998. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257.
5. Botkin JR, Croyle RT, Smith KR, Baty BJ, Lerman C, Goldgar DE, Ward JM, Flick BJ, Nash JE. 1996. A model protocol for evaluating the behavioral and psychosocial effects for BRCA1 testing. J Natl Cancer Inst 88:872-882.
6. Bratt O, Kristoffersson U, Lundgren R, Olsson H. 1997. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 50:360-365.
7. Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, Brensinger JD, Johnson K, Bacon JA, Booker SV. 1999. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology, Biomarkers Prev 8:345-351.
8. Croyle RT, Lerman C. 1993. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med 22:284-292.
9. Geller G, Bernhardt BA, Helzlsouer K, Holtzman NA, Stefanek M, Wilcox PM. 1995. Informed consent and BRCA1 testing. Nat Genet 11:364.
10. Glanz K, Grove J, Lerman C, Gotay C, Le Marchand L. 1999. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev 8(4 Part 2):329-336.
11. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson, M. 1991. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600.
12. Gruber SB, Almog R, Low M, Rennert G. 1999. APC I1307K allele and the risk of hepatocellular carcinoma. Am Soc Clin Oncol Progr/Proc 18: 2365.
13. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y. 1991. Identification of FAP locus genes from chromosome 5q21. Science 253:661-665.
14. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton AR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B. 1997. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17:79-83.
15. Lerman C, Seay J, Balshem A, Audrain J. 1995. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 57:385-392.
16. Lerman C, Marshall J, Audrain J, Gomez-Caminero A. 1996a. Genetic testing for colon cancer susceptibility: anticipated reactions of patients and challenges to providers. Int J Cancer 69:58-61.
17. Lerman C, Narod S, Shulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H. 1996b. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 275:1885-1892.
18. Lerman C, Biesecker B, Beckendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM. 1997. Controlled trial of pre-test education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89:148-157.
19. Lerman C, Hughes C, Track BJ, Myers RE, Main D, Bonney A, Abbaszadegan MR, Harty AE, Franklin BA, Lynch JF, Lynch HT. 1999. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 281:1618-1622.
20. Lothe RA, Hektoen M, Johnsen H, Meling GI, Andersen TI, Rognum TO, Lindblom A, Borresen-Dale AL. 1998. The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer. Cancer Res 58:2923-2924.
21. Patenaude AF, Basili L, Fairclough DL, Li FP. 1996. Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition. J Clin Oncol 14:415-421.
22. Petersen GM, Larkin E, Codori AM, Wang CY, Booker SV, Bacon J, Giardiello FM, Boyd PA. 1999. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients. Cancer Epidemiol Biomarkers Prev 8:337-344.
23. Petrukhin L, Dangel J, Vanderveer L, Costalas J, Bellacosa A, Grana G, Daly M, Godwin AK. 1997. The I1307K APC mutation does not predispose to colorectal cancer in Jewish breast and breast-ovarian cancer kindreds. Cancer Res 57:5480-5484.
24. Redston M, Nathanson KL, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcelik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinsky L, Schrag D, Gallinger S, Kaback M, King MC, Woodage T, Brody LC, Godwin A, Warner E, Weber B, Foulkes W, Offit K. 1998. The APCI1307K allele and breast cancer risk [letter; comment]. Nat Genet 20:13-14.
25. Richards CS, Ward PA, Roa BB, Friedman LC, Boyd AA, Kuenzli G, Dunn JK, Plon SE. 1997. Screening for 185delAG in the Ashkenazim. Am J Hum Genet 60:1085-1098.
26. Smith KR, Croyle RT. 1995. Attitudes toward genetic testing for colon cancer risk. Am J Public Health 85:1435-1438.
27. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. 1995. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4: 169-173.
28. Tambor, ES, Rimer BK, Strigo TS. 1997. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am J Med Genet 68:43-49.
29. Woodage T, King SM, Wacholder S, Hartge P, Struewing JP, McAdams M, Laken SJ, Tucker MA, Brody LC. 1998. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 20:62-65.